The deal struck with Helsinn Group is the latest evidence of the new opportunities for IP monetisation provided by hub-and-spokes life sciences companies
The deal struck with Helsinn Group is the latest evidence of the new opportunities for IP monetisation provided by hub-and-spokes life sciences companies